Zur Bestimmung der spezifischen Histidindecarboxylase
- 1 January 1967
- journal article
- research article
- Published by Walter de Gruyter GmbH in Hoppe-Seyler´s Zeitschrift Für Physiologische Chemie
- Vol. 348 (Jahresband) , 319-322
- https://doi.org/10.1515/bchm2.1967.348.1.319
Abstract
The decrease in histamine formation 10 min. after the addition of thyroid extracts is caused by the following factors: the consumption of histamine by diamine oxidase and histamine methyltransferase (largely inhibited by aminoguanidine and chlorpromazine) the formation of a complex between histidine and pyridoxal phosphate; the instability of the enzyme (decreased by glutathione); incubation under N2 (avoided by using O2). Optimal conditions for determination of specific histidine decarboxylase of thyroid glands are: 6.25x10-4 M aminoguanidine, 1x10-3 M chlorpromazine, 10-2 M glutathione and substrate saturation (10-2 M histidine). Under these conditions about 12,7 pmoles histamine/ mg protein and min., i.e. 27 [mu]g histamine/100 mg prptein and 3 h were formed, respectively. 1x103 M aminoguanidine and 5x10-3 M chlorpromazine inhibit the specific histidine decarboxylase by 90%. The importance of these results for the detection and determination of the specific histidine decarboxylase of various organs, and the sensitivity and specifity of fluorometric and isotopic methods are discussed.This publication has 5 references indexed in Scilit:
- Histamin und histidindecarboxylasen in schilddrüse und thymusBiochemical Pharmacology, 1966
- A rotating diffusion chamber for C14O2 determination as applied to inhibitor studies on mouse mast cell tumor histidine decarboxylaseAnalytical Biochemistry, 1964
- The Distribution and Properties of a Histamine-methylating EnzymeJournal of Biological Chemistry, 1959
- A METHOD FOR THE FLUOROMETRIC ASSAY OF HISTAMINE IN TISSUES1959
- DOPA DECARBOXYLASE INHIBITION THROUGH THE INTERACTION OF COENZYME AND SUBSTRATEJournal of Biological Chemistry, 1952